普通外文研报
Kone (AO) | Buy | Clear beat on order intake, in-line adjusted EBIT margin in Q2, 2026 outlook unchanged
研报英文原文证据摘录
Kone (AO) | Buy | Clear beat on order intake, in-line adjusted EBIT margin in Q2, 2026 outlook unchanged
Kone Buy | Target Price: EUR68.00
Company description Management
Post-merger Kone/TKE would be the global elevator and escalator leader, with Philippe Delorme (CEO)
c.22% value share after likely remedies. The group combines Kone’s Asian scale, Ilkka Hara (CFO)
digital capabilities and innovation base with TKE’s service-heavy franchise, Antti Herlin (Chairman)
installed base and Americas platform. It would offer a more balanced, Key shareholders
aftermarket-led profile, with stronger route density, modernisation reach, R&D Free float 62.67%
scale and targeted EUR700m annual cost synergies. The closing of the deal is Herlin Antti 23.35%
slated for Q2 2027 at the earliest. Polttina Oy 3.26%
Investment case Valuation methodology
The remaining hurdle for the Kone/TKE merger is antitrust, We employ a dual valuation approach, using the weighted
where we expect Germany-led European field remedies rather average fair value derived from a target multiple and our DCF
than deal prohibition. Our base case assumes Kone still retains model.
c. 85% of TKE sales and c. 80% of TKE adjusted EBITDA. We use an EV/EBITDA 2030E target multiple of 17x and discount
The industrial logic is strong and margin-relevant. Kone/TKE is a back the resulting fair value back to 12 months from now.
service-density, geographic-rebalancing and platform-efficiency Moreover, we use a three-stage DCF model with a ten-year time
deal. Even after remedies, the combined group would become horizon (WACC: 8.0%, TG: 2.25%).
the global E&E leader with c. 22% value share. Risks to our rating
The deal targets c. EUR700m cost synergies plus c. EUR200m Antitrust/remedy risk is the key downside case.
本摘录由系统从所标注的 PDF 证据页直接提取并保留英文原文,不做批量翻译;登录后在阅读器切换中文时才按需翻译。
打开研报阅读器